|Articles|August 13, 2020
- Applied Clinical Trials-08-01-2020
- Volume 29
- Issue 7/8
Applied Clinical Trials, August 2020 Issue (PDF)
Click here for a link to open the Applied Clinical Trials August 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Integration of Biomarker Validation in Oncology Trialsalmost 6 years ago
Immunomodulators and Cancer Researchalmost 6 years ago
COVID Exposes the Cracks in Trial Problemsalmost 6 years ago
The RACE for Children Act Takes Effect This Monthalmost 6 years ago
Designing Cell Therapies to Target Solid Tumorsalmost 6 years ago
The Importance of Biomarker Managementalmost 6 years ago
Clinical Trials Can Duck the European GMO Problemalmost 6 years ago
Clinical Trial At-Home Service Providersalmost 6 years ago
News Notesalmost 6 years ago
Initial Design Considerations for Immuno-Oncology TrialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials at the 2026 DIA Global Annual Meeting: Conversations on Data, Outsourcing, and the Patient Voice
2
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
3
ACT Brief: Bridging Site-Sponsor Data Gaps, Major Study Retraction, and TNBC First-Line Approval
4
ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion
5